Enhanced efficiency of prodrug activation therapy by tumor-selective replicating retrovirus vectors armed with the Escherichia coli purine nucleoside phosphorylase geneC.-M. Tai, Noriyuki Kasahara, Y-H Lai et al.|Cancer Gene Therapy|2010Cited by 42